ASCO Colorectal Cancer | Conference

Liquid Biopsy to Inform Targeted Tx of Colorectal Cancer
June 21, 2018

In this video, Dr. Heinz-Josef Lenz outlines the many advantages that development of liquid biopsy is affording cancer patients.

Adjuvant FOLFOX Improved DFS in yp Stage III Rectal Cancer
June 06, 2018

In the ADORE trial, adjuvant FOLFOX in postoperative yp stage III rectal cancer significantly improved disease-free survival.

Second-Line Irinotecan/Cetuximab/Ramucirumab Combo Ups PFS in Advanced CRC
June 06, 2018

A combination of irinotecan, cetuximab, and ramucirumab may boost PFS in advanced CRC, when given after failure of oxaliplatin-and-bevacizumab–based therapy.